MARKSANS PHARMA LTD. - 524404 - Reg. 34 (1) Annual Report
Attached pl find Annual Report of Marksans Pharma Limited for the FY 2018-2019.28-08-2019
28-08-2019
MARKSANS PHARMA LTD. - 524404 - Intimation Of Book Closure Dates
Marksans Pharma Ltd''s share transfer book will remain closed from Saturday, 21st September, 2019 to Thursday, 26th September, 2019 (both days inclusive) on account of Annual General Meeting and payment of dividend, if declared at the AGM.28-08-2019
MARKSANS PHARMA LTD. - 524404 - 27Th Annual Genera Meeting Scheduled To Be Held On 26Th September, 2019.
Attached pl find the Notice for convening the 27th Annual Genera Meeting of Marksans Pharma Limited to be held on 26th September, 2019.28-08-2019
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation
We are attaching fresh investor presentation for Q1 FY20192020 in replacement of the earlier presentation as uploading of earlier presentation was not proper09-08-2019
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation
Attached pl find an investors presentation of Marksans Pharma Limited09-08-2019
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed herewith kindly find a News Release dated 9th August, 2019 of the Company.09-08-2019
Marksans Pharma Ltd - 524404 - Unaudited Financial Results For The Quarter Ended 30 June 2019 (Standalone And Consolidated).
In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Unaudited Financial Results for the quarter ended 30th June, 2019 (both Standalone and Consolidated) approved by the Board of Directors at its meeting held today i.e. 9th August, 2019 along with Limited Review Reports thereon. The meeting commenced at 11:50 a.m. and concluded at 01:15 p.m. In this connection, we hereby certify that the Auditors have given their reports on the Unaudited Financial Results for the quarter ended 30th June, 2019 (both Standalone and Consolidated) with unmodified opinion.09-08-2019
MARKSANS PHARMA LTD. - 524404 - Board Meeting Intimation for Notice Of Board Meeting Dated 9Th August, 2019
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve This is to inform you that the Meeting of the Board of Directors of the Company will be held on Friday, 9th August, 2019 at Mumbai, to consider and approve the Unaudited Financial Results of the Company (both Standalone and Consolidated) for the quarter ended 30th June, 2019. Please note that as per the Insider Trading Code of the Company, the Trading Window for dealing in Company's shares is closed for the Company's insiders from 1st July, 2019 and will remain closed till Forty-Eight hours after the announcement of the Financial Results on 9th August, 2019.31-07-2019
Marksans Pharma Ltd - 524404 - Clarification:
This has reference to the NSE e-mail communication dated 19th July, 2019 for clarification regarding appointment of Mr. Abhinna Sundar Mohanty (DIN: 00007995) as an Independent Director. In this connection we would like to state that the date of appointment of Mr. Abhinna Sundar Mohanty as an Independent Director is 11th July, 2019.22-07-2019
Marksans Pharma Ltd - 524404 - Shareholding for the Period Ended June 30, 2019
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click here18-07-2019